News

CEO Shaun Bagai Shares Insights at Upcoming Virtual Conference

CEO Shaun Bagai Shares Insights at Upcoming Virtual Conference

Shaun Bagai to Present at iAccess Alpha Conference

MOUNTAIN VIEW, Calif. — RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a pioneering company in life sciences dedicated to developing innovative oncology therapies, has officially announced that their CEO, Shaun Bagai, will be addressing participants at the iAccess Alpha Virtual Best Ideas Fall Investment Conference. This important event will take place soon and will bring together key investors and industry experts.

Examining the Innovation and Market Demand

During his presentation on September 16, Bagai will provide insights into RenovoRx’s ongoing commercialization strategy for its pioneering drug-delivery device, RenovoCath. The goal is to address the pressing clinical needs that have emerged in the oncology market. The conversation will delve into the rising organic revenue growth due to the increasing recognition and demand for RenovoCath, not just from new clients, but also from existing ones.

Key Highlights on Clinical Trials

One of the focal points of the presentation will be the latest updates from RenovoRx’s Phase III TIGeR-PaC clinical trial. This trial is particularly vital as it assesses the product candidate involving intra-arterial delivery of gemcitabine using the RenovoCath device. This innovative approach aims to treat locally advanced pancreatic cancer (LAPC) effectively. Bagai will share the encouraging recommendation received from the Data Monitoring Committee (DMC) to continue the trial following a thorough analysis of recent interim results.

Event Details and Importance

Now, let’s talk about the key details regarding this significant investment conference:

Date: September 16-17, 2025
Presentation Time: Tuesday, September 16 at 12:30 PM ET
Webcast Link: Access the webcast for more insights.

Importance of Investor Engagement

Engagement with investors is crucial for RenovoRx as they navigate their growth trajectory in the highly competitive landscape of medical technology. Bagai will encourage investors to schedule one-on-one meetings to discuss how RenovoRx’s innovative solutions are transforming oncology treatments.

About RenovoCath and Its Applications

RenovoCath, recognized for its groundbreaking design, is intended to optimize the delivery of treatments while isolating blood flow to enhance therapeutic effects directly at tumor sites. This FDA-cleared device is not just impactful for chemotherapy delivery, but also applicable for arteriography and surgeries, showcasing its versatility in healthcare settings.

The Future of Targeted Therapies

RenovoRx is committed to addressing substantial unmet medical needs within oncology. Their technology platform, Trans-Arterial Micro-Perfusion (TAMP™), illustrates their dedication to advancing therapeutic excellence and transforming patient outcomes while minimizing side effects often associated with traditional intravenous therapies.

Continued Innovation and Commercial Success

In a significant achievement, RenovoRx has begun to commercialize RenovoCath, successfully securing its initial purchase orders. Furthermore, repeat orders from existing clients indicate a positive reception in the market, signaling strong demand for its innovative technologies. Their focus remains on expanding partnerships with medical institutions and enhancing revenue streams through strategic collaborations.

Looking Ahead

As the company moves forward, it continues to evaluate new markets and potential collaborations that can facilitate broader access to its technologies, all while focusing on the core mission of improving patient lives impacted by cancer therapies. Investors and stakeholders remain optimistic about RenovoRx’s future contributions to medical advancements.

Frequently Asked Questions

What is RenovoRx’s main product?

RenovoRx is best known for its innovative drug-delivery device, RenovoCath, designed to enhance oncology treatments.

When will Shaun Bagai present at the conference?

Shaun Bagai’s presentation is scheduled for September 16, 2025, at 12:30 PM ET.

What is the TIGeR-PaC clinical trial?

The TIGeR-PaC trial evaluates the delivery of intra-arterial gemcitabine using RenovoCath for patients with locally advanced pancreatic cancer.

How can investors learn more about RenovoRx?

Investors can access more information by attending the iAccess Alpha conference or contacting RenovoRx’s investor relations.

What regulatory approval does RenovoCath have?

RenovoCath is an FDA-cleared device intended for various therapeutic applications, including chemotherapy delivery.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Insta360 Expands with Times Square Flagship Store

Updated Category News Views 5

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
Fast Guard Elevates Nationwide Fire Watch Mission

Updated Category News Views 2

Fast Guard: The Unseen Shield Behind Property Safety Hollywood, Florida might be best known for its sun-kissed beaches, but in the world of fire safety, it’s the nerve center for emergency fire watch response. Fast Guard Service isn’t just any run-of-the-mill security outfit; it’s rapidly becoming the unsung hero of property managers across the nation. When those...

Continue Reading
China's Tech Success Echoes in Global Living Rooms

Updated Category News Views 4

A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...

Continue Reading
Why Liver Nurture Taps into Health Sector Trends

Updated Category News Views 4

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Continue Reading
Chery Auto's Bold Green Tech Showcase at 2026 Summit

Updated Category News Views 2

Chery Auto Puts Eco Tech at Front and Center You know, Chery Auto isn't just manufacturing cars anymore—it's shaping an entire lifestyle. For the uninitiated, they’re calling in everyone worth knowing to their headquarters in Wuhu, China, come October 18 through 24. The 2026 Chery International User Summit is kind of a big deal this year with nearly 20 new green...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 5

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
Med Spa Visits: Key Insights from Lindsey Smith

Updated Category News Views 3

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Continue Reading
2026 Lantern Festival Shines in Kunshan Amid Tensions

Updated Category News Views 4

Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...

Continue Reading
Papa John's Faces Class Action Over Misleading Info

Updated Category News Views 0

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

Continue Reading
Hainan Airlines' Dedication Keeps It atop Skytrax

Updated Category News Views 5

Fifteen years of soaring high: now that's something worth taking to the bank—or the air. Hainan Airlines has just bagged the SKYTRAX Five-Star Airline rating once again, handed out at this year's World Airline Awards ceremony. When it comes to delivering quality, they're flying high on the charts, landing among the World's Best Airlines Top 10. And in the wild world of...

Continue Reading

Top 5 Most Recently Viewed Articles

C4 Therapeutics Reports Strong Q1 2025 Performance Highlights

Updated Category News Views 292

Financial and Operational Highlights from C4 Therapeutics C4 Therapeutics, Inc. (C4T) (NASDAQ: CCCC), a pioneering clinical-stage biopharmaceutical company focused on targeted protein degradation, has released its financial results for the first quarter of 2025, along with significant business updates. As of now, C4 Therapeutics has reported strong advancements in its...

Continue Reading
Rocket Lab Successfully Deploys Synspective Satellite with Electron

Updated Category News Views 205

Rocket Lab Marks Milestone with Latest Launch Rocket Lab Corporation (NASDAQ: RKLB), a renowned leader in launch services and space systems, has achieved another significant milestone. Recently, they successfully completed their 15th mission this year, delivering the seventh StriX satellite into orbit for Synspective. This accomplishment showcases Rocket Lab's expertise...

Continue Reading
Potential Growth of UiPath and Roku: Analysts Predict High Returns

Updated Category News Views 197

The S&P 500 showed impressive growth back in 2024, spurred by the surge in artificial intelligence interest and some solid economic indicators. In this atmosphere, analysts flagged two players worth keeping an eye on—UiPath and Roku—as potentially undervalued stocks poised for significant upside. UiPath: RPA's Heavyweight? UiPath was all about robotic process...

Continue Reading
Mediaplanet Initiates 2025 Campaign to Raise Rare Disease Awareness

Updated Category News Views 268

Mediaplanet Launches Campaign to Promote Rare Diseases Awareness Today marks the launch of Mediaplanet's campaign focused on rare diseases, coinciding with Rare Disease Day. This initiative is designed to provoke essential discussions by highlighting personal experiences from individuals affected by these conditions and informing the public about the various challenges...

Continue Reading
Agilysys Spa Clinches Prestigious Award with AI Innovations

Updated Category News Views 172

Agilysys Spa's Remarkable Recognition at G2E 2024 Agilysys, Inc. (Nasdaq: AGYS), a premier global provider of hospitality software solutions, has recently seen its guestsense.ai technology earn significant accolades. This sophisticated application of artificial intelligence is integrated within various Agilysys offerings, enhancing revenue management, personalizing guest...

Continue Reading